ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0001151.1|Clavams_1 # 1 # 2532 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.687	BGC0001151.1|Clavams_1 	1	2532	+	Loose	400	33.4982	kdpE	31.03	3003841	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	kdpDE	GTGTTACCGGTAGATAACGTTGTCAGCAATGCCGTCGATCCCCTCACACCCTCCATTGAGGCTTTCGGCCATATGAGAGTCCGCATCGGACAGCGTGAAGTCGCCCTGGGCTCCCCTCGGCAGCGTGCCCTGTTCGCGGTTCTGCTCATCAGCGTCGGCAAGACCGTGCCCGTACACGACATCATCAATTGCATATGGGGGCCGGCTCCCCCATCGGCCGTGACCGGCACGCTCCACTCCTATGTCTCCCGGCTCCGCAAAGCCATCTCCGATGTCCTGACGACACGGCACGAGATCCTCGTCAGCATGCGTCACGCGGCTCCCGGATATCAGCTGGACATCTCACCGGAAGGCACCGACGTCCACCGGTTCGAACAGCTCGTGGAGTCCGGCCGCACCCACTTCTCCGCCGGAGACCTGCCCGAGGCACGCAGGGACCTCGATCGGGCGATGGCGCTGTGGACGGACACGCCCTACAGCGAACTGGCGTCGTACGACTTCGCGGCTCTGGAAGCGAGCCGTCTGGACCAACTGCGCCTCCAGGCCCTGCAGATCTGGGCCGACGCGTGCCTGCACCTCGGGGCGCACGACGAGGTGGTCCGGGAACTGAGCAAGGAGATCCGCCGCAACCCCATGCTGGAGCGGCTGGGCAGCCAGTTGATGCTGGCGCAGTACCACAGTGGTTCACCCGCGGAAGCCCTCATGACGTACGAGCGGATCCGCTCCCATGTCTCCGCCGAACTCGGCGCCGACACCAGCAAGGAACTCCAGGAGATCCACCAGTCGATCCTGCGCCAGGACCTGCCGGTCGTACCACCCCGGCCCCTGCTCGAAAGCCGGCCTGTGGTACTCACCGCACCTTCGGTCCGGACGAATCCGGTCCAGGCGAATCCGGTTCAGGCAGGTCCCGTTCAGGCAACTCCGGTTCAGGCGGATCCGGTCCACGCGCGTCCGGTCGGCACGTCCCCCGCGGTCCCGGCGCCCGTCTCCGCGGACGTCCCGGTCCGACCCCGGCCCCGGCCACGGCCGGCCGGAGCGGTACCCCCGATCGGCAGCCTCATCGGGCGGGAGCGCGAGATGGAGCAACTGCGCTCGATGGTGACGGGCGACTTCCCCCGGCGGACCGTGCTGATCACCGGTGAACAGGGAATCGGCAAGACCCGTCTGCTCAAGGAACTGGCACGCGAACTCGGGCCGGACAGGCCGGAGGTGATCTGGGCGCACTGCACCGGCCGTGGCAGCCGCCGGACTTGGGGCCAGGTCGTTCAGAAAGTGCTCCGGGTGCGCGGGAACGCGCTGCACGGCTGTTCGTCGGGCGCCGGGCCCGGGACGCCTCCCCCGCACGAGTGCCACCGGCCCTCGGACGGCGACCTCGGGCAGGCGCACCTCGACGACACGGCCTACCAGCAAGCCGTGGTGCATCTGCTGCTCACCGCCGCGGCGGACGAGCCGCTGGTGATCGTGCTGGAGGACCTCCACCTGGCCGACACCCACACCCTCGAACTACTGCGTCTGCTCACCATGGAGGGCCAGGAAGCCCACCTCGTGGTCCTCGCGACCGTGCAGGAACACTCCCTCGCTCGCCTTCCCGATCTGCGGCGCGCGACGGCCGACCTGCTGCGCACGGACGGCGTGGGGAACCTCCATCTGACCGCGCTCTCCCCGGTCCAGGCGCACGCGCTGATCCACGAACTGCATGAAGCGCCCGTCCCCTGGCACCACGTGTCGTTCCTCCACCGGGCCACCGGGGGCAACCCGTACCTGCTCACCGCGCTCGCCAGACACGAGGATCTGACCAACGTCCACAAGGACCTCCTCGCGTCCCTCTCGTTCGACGTCAGGACGGTGCTGCTCAGCCGGCTCGCCGAGCATCCGCTCGAGGCGATCGCCGTGCTGGAGGTGTGCGCGGTCATGGGGCCGGTCATCGACCACTACCTGCTCACCTCTGTCCTCGACCAGCGGGGTATGACCGGTACCGTCAAGGAAGCACTGGACACCGGTCTCCTCACCCGCAACCCCGCCGATCCCGGCGATCTGCGGTTCAGCCAGTACCTGATACGGGACTATCTGCTCGCGGGACTGGACGCCGTGCTGAAGGCACAGTTGCACCTGAGCATCGCCCAGGCACTGGCCGAGCGGACCGCGCACAGTTCCCGGTCGGTCGTCGGCCCCGACCTGACGCATCACTGCACGCAGGCCGCCGTGGCCCTGGATCCGCATGAGGCGGTGCAGCCGATGATCGCACTCGCCGACCGGGCCGAGGCCCTCAAGCGTTGGGGCGAGGTGGTGATGTGGCTGGCGCAGGCCTCCGCCGTCCTCCGCTCCCGTCCGCTGCGCGGTGAGGCCGTGCATGCCGACCGCGCACTGCAGGAACGGCTGGCCCGCGTGAGGGCCACCTGTTTCCGCTGCCCGACCAGCAGGCCGTGTCCGAAGGCGGAGAACAGCAACGCTATCCTCCGGCGGAATCTGCCGGGCGCGTGCTACACGCCCCGGCCCGCGACGATGATCACAGCGGCCCGGCAGGAAACTTGA	VLPVDNVVSNAVDPLTPSIEAFGHMRVRIGQREVALGSPRQRALFAVLLISVGKTVPVHDIINCIWGPAPPSAVTGTLHSYVSRLRKAISDVLTTRHEILVSMRHAAPGYQLDISPEGTDVHRFEQLVESGRTHFSAGDLPEARRDLDRAMALWTDTPYSELASYDFAALEASRLDQLRLQALQIWADACLHLGAHDEVVRELSKEIRRNPMLERLGSQLMLAQYHSGSPAEALMTYERIRSHVSAELGADTSKELQEIHQSILRQDLPVVPPRPLLESRPVVLTAPSVRTNPVQANPVQAGPVQATPVQADPVHARPVGTSPAVPAPVSADVPVRPRPRPRPAGAVPPIGSLIGREREMEQLRSMVTGDFPRRTVLITGEQGIGKTRLLKELARELGPDRPEVIWAHCTGRGSRRTWGQVVQKVLRVRGNALHGCSSGAGPGTPPPHECHRPSDGDLGQAHLDDTAYQQAVVHLLLTAAADEPLVIVLEDLHLADTHTLELLRLLTMEGQEAHLVVLATVQEHSLARLPDLRRATADLLRTDGVGNLHLTALSPVQAHALIHELHEAPVPWHHVSFLHRATGGNPYLLTALARHEDLTNVHKDLLASLSFDVRTVLLSRLAEHPLEAIAVLEVCAVMGPVIDHYLLTSVLDQRGMTGTVKEALDTGLLTRNPADPGDLRFSQYLIRDYLLAGLDAVLKAQLHLSIAQALAERTAHSSRSVVGPDLTHHCTQAAVALDPHEAVQPMIALADRAEALKRWGEVVMWLAQASAVLRSRPLRGEAVHADRALQERLARVRATCFRCPTSRPCPKAENSNAILRRNLPGACYTPRPATMITAARQET	MTNVLIVEDEQAIRRFLRTALEGDGMRVFEAETLQRGLLEAATRKPDLIILDLGLPDGDGIEFIRDLRQWSAVPVIVLSARSEESDKIAALDAGADDYLSKPFGIGELQARLRVALRRHSATTAPDPLVKFSDVTVDLAARVIHRGEEEVHLTPIEFRLLAVLLNNAGKVLTQRQLLNQVWGPNAVEHSHYLRIYMGHLRQKLEQDPARPRHFITETGIGYRFML	374.67	gnl|BL_ORD_ID|2163|hsp_num:0	2331		
BGC0001151.1|Clavams_2 # 2771 # 4117 # 1 # ID=1_2;partial=00;start_type=TTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.712	BGC0001151.1|Clavams_2 	2771	4117	+	Loose	500	28.8758	sul3	28.3	3000413	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	TTGACCACTTCCATGCCCACCGTACGGCCGGACCGGCGCCACCTTGCGTCCGGGATTCCCGGTCCCCTTTCCAGCGCCTTCGAGGCACGGCGTCGCGCCGCGGTCGCCAGGGGCGTCGGCAGCGCCGTTCCCGTGTACGCGGCAGCGGCGGATCCCGGTCTGCTGCACGACATAGACGGGAACGCGTTCATCGACCTCGCGTCCGGTCTCGGTGTGACGGCGGTGGGCAACGCGGCCCCGGACGTCGTCGCGGCGGTCCGCGAGCAAGTGGGGCTGTTCACCCACACCTGTTTTCTGACCAGCCCCTACTCCGGGTACGTGGAGGTGTGCGAGGAGCTGTCGAACCTCACGCCCGGCCGTCATGAGAAGCGCAGCGTTCTGCTGAGCACGGGTGCCGAAGCGGTGGAGAACGCCGTCAAGGTCGCCCGGGCCGCCACCGGCCGCAGCGCCATCGTGGTGCTGGACCACGCCTACCACGGACGCACCAACCTCGCTCTGGGCATGACCGCGAAGAACGCGCCGTTCAAGCAGGGCTTCGGCCCGTTCGCCCCCGACATCCACCGGGTCCCCACCTCGTACCCGTACCGCGACCCGCAGGGCATGACCGGCGAGGAAGCGGCCCAGCGCGCCCTTGAGGCTCTGGAACGCCAGGTCGGCGGGGAGAACGTGGCCGCCATCGTCGTCGAACCGGTGCAGGGCGAGGGCGGGTTCATCGTGCCGGCTCCCGGTTTCCTGCCCGCGCTCCAGAGCTGGTGCCGGGAGCACGGAGCCCTGTTCGTCGCCGACGAGATCCAGAGCGGGTTCTGCCGTACCGGCGCCTGGTTCGCCAGCGAGCACGAGGACCTCGTACCGGACCTGGTGATCACCGCCAAGGCACTGGCCGGCGGGCTGCCCCTGTCCGCCGTGACCGGGCGGGCCGAGATCATGGACGCGGTGCAACTCGGTGGCTTCGGCGGTACCTACGGTGGCAACCCGGTCGCCTGCGCCGCCGCTCTGGCGTCCATCGAGGTGATGCGCACCGGGCACCTCGTCGACAGCGCACGTGCGATCGGCGACACCCTGTTCACCCGCCTGCGCGCCCTCGCCGTGCGGCATCCGGCCATCGGCGAGGTCCGGGGGCGCGGGGCGATGGTGGGTGTCGAGATCGTCGAGCCCGGCGGCAGGCGGCCCGGCGCCGAGGCGGCCCAGCGGCTGGCCAAGGCCTGTCAGCAGCGCGGGGTGCTGCTCCTGACCGCCGGGACCCACAGCAACGTCCTGCGGTTCCTGCCTCCTCTCGTCATTCCTCCGGCCCTGCTGAACGACGCGGTCGACGTCATCGAGGAGTGCTGTGACGAACTCCTCGCATGA	MTTSMPTVRPDRRHLASGIPGPLSSAFEARRRAAVARGVGSAVPVYAAAADPGLLHDIDGNAFIDLASGLGVTAVGNAAPDVVAAVREQVGLFTHTCFLTSPYSGYVEVCEELSNLTPGRHEKRSVLLSTGAEAVENAVKVARAATGRSAIVVLDHAYHGRTNLALGMTAKNAPFKQGFGPFAPDIHRVPTSYPYRDPQGMTGEEAAQRALEALERQVGGENVAAIVVEPVQGEGGFIVPAPGFLPALQSWCREHGALFVADEIQSGFCRTGAWFASEHEDLVPDLVITAKALAGGLPLSAVTGRAEIMDAVQLGGFGGTYGGNPVACAAALASIEVMRTGHLVDSARAIGDTLFTRLRALAVRHPAIGEVRGRGAMVGVEIVEPGGRRPGAEAAQRLAKACQQRGVLLLTAGTHSNVLRFLPPLVIPPALLNDAVDVIEECCDELLA	MSKIFGIVNITTDSFSDGGLYLDTDKAIEHALHLVEDGADVIDLGAASSNPDTTEVGVVEEIKRLKPVIKALKEKGISISVDTFKPEVQSFCIEQKVDFINDIQGFPYPEIYSGLAKSDCKLVLMHSVQRIGAATKVETNPEEVFTSMMEFFKERIAALVEAGVKRERIILDPGMGFFLGSNPETSILVLKRFPEIQEAFNLQVMIAVSRKSFLGKITGTDVKSRLAPTLAAEMYAYKKGADYLRTHDVKSLSDALKISKALG	170.34	gnl|BL_ORD_ID|368|hsp_num:0	396		
BGC0001151.1|Clavams_4 # 5224 # 6426 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.693	BGC0001151.1|Clavams_4 	5224	6426	-	Loose	300	26.5646	AAC(3)-IXa	35.09	3002543	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGGACGTACTGGAAGTCCTGCGGCGCAAGCCCAGCCTCAACTTGTTCCCCATCGAGAACAGGCTTTCCCCGAGGGCCCGGGAGGCACTGGCCAGCGACGCGAACAACCGCTACCCCTACGTCGAGGGCCCGGTCTCGCACTACGGGGACGTCATGGGGCTGGGGGAGGTGTACGACTACTGCGTCGACCTGGCCAAGGAGTTCTACGGCGCCCGCCACGGGTGCGTGCACTTCCTGTCCGGCCTGCACACCATGTACACCGTCATCACCGCCCTGGTGCCAGCCGGCAGCCGCGTCATGGTCCTGCACCCAGAGGACGGCGGCCACTACGCCACCATCACGATCTGCGAGGGCCTGGGACACTCCGTCTCACGCCTGCCGTTCGACAGGAAGACCCTGCTGATCGACTACGAGGAACTCGCCGTCCAGCTCGCGGAGTCCCCCGTCGACGTCATCTACCTCGACGCCTCCAGCATGCTGCGCCTGCCCGACGCCCGGCTGCTGCGCCAGGCGGCACCGGACACCCTCCTGTGCCTGGACGCCTCCCACCTCATGGGCATCCTGCCGGCCGCTCCCAAGACCCTGGTCTTCGACGGCGGGTTCGACACCGTCTCGGGCAGCACCCACAAGACACTGCCCGGCCCGCAGAAGGGCCTGATGGTCACGAACGACGCGACGCTGGCCGGGAAGGTCATGGAGCGGATCCCGTTCACCGCCTCCAGCTCGCACGCCGGGAACGTCGGCGCACTCGCGATCACCCTGGAGGAGCTGATGCCCTGCCGGGTGGAGCACGCGCAGCAGATCATCGCCAACGCCCGTGAGCTGGCAGCCCAGTTGGCGCAGCGCGGGTTCAGCGTGGCGGGCGAGGAGTTCGGCTGGACCGAGACGCACCAGGTCTGGGCGTACATCCCCGAGGAGCAGGGGCCGCACGGCTGGGGCAGGGTGCTGACCCGGGCGAACGTACGCAGTACGACGGTTCCCCTGCCCAGCAGCGACGGCTTGCCGGCCCTGCGGCTGGGCACGCAGGAGCTCACCCGCAGCGGCATGAAGGAGGCCGAGATGACCGAGGTGGCCGACATCCTGGAGCGGCTCCTGCTGCGCGGTGAGGCGCCCGAGCAGGTGATCGGCACCGTCCGCGACCTCGCGCTCCGGTTCCCGGGCGTGTCCTGGATAGGTTCCGCGGACACCACGTCCGTCGATTGA	MDVLEVLRRKPSLNLFPIENRLSPRAREALASDANNRYPYVEGPVSHYGDVMGLGEVYDYCVDLAKEFYGARHGCVHFLSGLHTMYTVITALVPAGSRVMVLHPEDGGHYATITICEGLGHSVSRLPFDRKTLLIDYEELAVQLAESPVDVIYLDASSMLRLPDARLLRQAAPDTLLCLDASHLMGILPAAPKTLVFDGGFDTVSGSTHKTLPGPQKGLMVTNDATLAGKVMERIPFTASSSHAGNVGALAITLEELMPCRVEHAQQIIANARELAAQLAQRGFSVAGEEFGWTETHQVWAYIPEEQGPHGWGRVLTRANVRSTTVPLPSSDGLPALRLGTQELTRSGMKEAEMTEVADILERLLLRGEAPEQVIGTVRDLALRFPGVSWIGSADTTSVD	MEEMSLLNHSGGPVTRSRIKHDLADLGLKDGDVVIFHTRMSAIGYVAGGTQTIIGALLDVVGARGTLMVPCGWNNAPPYDFLDWPRDWQDALRAEHPAYDPDLSEADYNNGRLPEALPRWPGAIRSRHPDASFAALGPAAAELMAEHPWDHPHGPDTPLARLIAHSGRVLLLGAPLDTMTLLHHAEALADVRSKRFVTYEQPILVNGQRVWRQFRDIDSEEGAFDYSTVRRGVEPFEAIARDMLSAGIGRQGRVGAADSYLFDAGPVFNFAINWIEAKLKR	142.35	gnl|BL_ORD_ID|1915|hsp_num:0	2030		
BGC0001151.1|Clavams_5 # 6793 # 8508 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.699	BGC0001151.1|Clavams_5 	6793	8508	+	Loose	300	31.187	Escherichia coli soxR with mutation conferring antibiotic resistance	51.72	3003381	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	antibiotic target alteration; antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCACGCGTGTCCACCAGCCCTTCCACTTCCCCCACCACCGCACACGCCCTGCTCCAGCGCCTCCGTGATCACGGCGTGCGCACCGTGTTCGGTGTGGTCGGCCGGGAGGCGGCGTCGATCCTCTTCGACGAGGCGGAGGGCATCGACTTCGTGCTGACCCGGCACGAGTTCACCGCCGGGGTCGCCGCCGACGTGGTGGCCCGCATCACCGGCCGGCCGCAGGCATGCTGGGCCACCCTGGGCCCGGGTATGACCAACCTGTCCACCGGCGTCGCCACCTCCATACTCGACCGGTCGCCCGTCATCGCGCTGGCGGCCCAGTCGGAGTCGCACGACATCTTCCCCAACGACACCCACCAGTGCCTGGACTCGGTGTCGGTGATGGAGCCGATGACCAAGTACGCGGTGGAACTTCAGCGGCCGGACGACATCGTCGACCTGGTGGACTCCGCGGTGTCGGCCGCGATGACCGAGCCGGTCGGCCCCAGCTTCATCTCCCTGCCGGTCGACCTGCTCGGCAGCGAGATCGACGCCTCCGTCGAGCACCCCGCGGCGAAGATGCCGTCCAAGCCCATCGGTGCCTTCGAGGAGGGCTGGGAGAAGGAGGCGGACAAGGCCGCCGAACTCCTCCGCTCGGCGCAGCACCCGGTGCTGGTCGTCGGTGCCGCCGCGATCCGTTCCGGCGCGGTGCCCACCATCCGCGCCCTGGCCGAGCGCCTGCGCATCCCCGTCATCACCACCTACATCGCCAAGGGCGTCCTGCCCCAGGGCCACGAGCTGAGCTACGGCGCGGTCACCGGCTACATGGACGGCATCCTGTCCTTCCCGGCCCTGGAGACCCTGTTCGGCCCGGCGGACCTCATCCTGACGGTCGGGTACGACTACGCCGAGGACCTGCGGCCGTCGATGTGGCAGCGCGGCGGCGCGAAGAAGACCGTGCGGGTGTCGCCGACGGCCAACCCGATCCCGCGGGTCTACCGTCCCGACCTCGACGTCGTGACCGACGTGCAGGCGTTCATGACGCACCTGGACGAGCGGACGGCCGGATTCGACGCGAAGACCCCGCACGACATCACCCCGCTGCGCGAGCGGATCAGCGAGTTCCTGGCCGACCCGGCCCAGTACGACGACGGCATGCGCGTGCACCAGGTCATCGACTGCATGAACACCGTCATGTCGGAGACCGCGGAGTCCGGCGAGGGCACGATCGTCTCCGACATCGGTTTCTTCCGGCACTACGGGGTCCTCTTCGCCCGTGCCGACCAGCCGTTCGGCTTCCTCACCTCGGCCGGCTGCTCCAGCTTCGGATACGGTCTGCCCGCGGCGATGGGCGCCCAGATCGCCCGGCCCGGACAGCCCACCATGCTCATCGCGGGCGACGGCGGCTTCCACTCCAACAGCGCCGACCTGGAGACCATCGCCCGGCTCAACCTGCCGATCGTCACCGTCGTCGTCAACAACGACACCAACGGCCTGATCGAGCTGTACCAGAACATCGGCCACCACCGCTCCCACGACCCGGCGGTGAAGTTCGGCGGCGTCGACTTCGTCGGGCTCGCCCGCGCCAACGGCATCGAGGCGATCAAGGCCGGCACGCGCGAGGAGCTCCTGGCCGCGCTGCGCAAGGGAGCGGGACTGGGCCGGCCGTTCCTGGTCGAGGTGCCGGTCAACTACGACTTCCAGGCGGGCGGCTTCGGCGCCCTGAGCATCTGA	MSRVSTSPSTSPTTAHALLQRLRDHGVRTVFGVVGREAASILFDEAEGIDFVLTRHEFTAGVAADVVARITGRPQACWATLGPGMTNLSTGVATSILDRSPVIALAAQSESHDIFPNDTHQCLDSVSVMEPMTKYAVELQRPDDIVDLVDSAVSAAMTEPVGPSFISLPVDLLGSEIDASVEHPAAKMPSKPIGAFEEGWEKEADKAAELLRSAQHPVLVVGAAAIRSGAVPTIRALAERLRIPVITTYIAKGVLPQGHELSYGAVTGYMDGILSFPALETLFGPADLILTVGYDYAEDLRPSMWQRGGAKKTVRVSPTANPIPRVYRPDLDVVTDVQAFMTHLDERTAGFDAKTPHDITPLRERISEFLADPAQYDDGMRVHQVIDCMNTVMSETAESGEGTIVSDIGFFRHYGVLFARADQPFGFLTSAGCSSFGYGLPAAMGAQIARPGQPTMLIAGDGGFHSNSADLETIARLNLPIVTVVVNNDTNGLIELYQNIGHHRSHDPAVKFGGVDFVGLARANGIEAIKAGTREELLAALRKGAGLGRPFLVEVPVNYDFQAGGFGALSI	MEKKLPRIKALLTPGEVAKRSGVAVSALHFYESKGLITSIRNSGNQRRYKRDVLRYVAIIKIAQRIGIPLATIGEAFGVLPEGHTLSAKEWKQLSSQWREELDRRIHTLVALRDELDGCIGCGCLSRSDCPLRNPGDRLGEEGTGARLLEDEQN	370.78	gnl|BL_ORD_ID|2024|hsp_num:0	1005		
BGC0001151.1|Clavams_6 # 8511 # 10034 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.729	BGC0001151.1|Clavams_6 	8511	10034	+	Loose	450	29.261	ANT(4')-IIb	44.12	3002625	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(4')	ATGGCGGGATCCCTCCCGGCAGCCGTCGGTTTCCTCGCCGAGATCCGCCCGGACGGCGGCCCACCCCTGCGGCCCGACTTCGCGTCCCTCGGCGGGCGCACCGAACTGGCCGAGGACACCGGCGGTCAGAGTCTGCGAGCCGTGCTGCTGCACTCGGGCGCGCCGGACGGCGCCCACGCCCGTGACCGGGGCCGGACGGTGGTCTTCGCCGGCGAGCTGTACAACCGGGACGAACTTGCCCGGCTGCTGCCCGCCGGGCTGTCACCGGACAGCGACGCCGCCCTGGTGCTGGCCCTCTTCGGCAGCTACGACGTGCACGCCTTCCGGCTGCTCAACGGCCGTTTCGCGGCGCTGGTCGCGGCCGGGGAACGCGTCGTGCTCGCCACGGACCACGCGGGATCCGTGCCCCTGTACGCGTCCGTCGCCGCCGGCCGGGTGCTGGCGGCGACCGAGGCGAAGGCGCTGCGCGCAGCCACGGGCGGGCAGCCGCTGCCCGCCCGCCCGGTGCGGCGACTGACAGGTGTCCATCAGGTGCCCGCGGGGACCGTCCTGGACGTACGGGTGAGCACCGCGGAGTGTGTCGCCCACCGGACCTGGGCGCCCCCGCTGGCCCGGCGGATCGTCTCCGAGAACGAAGCCGTCGAGACAGTCCGGCAGGTCCTGGACCGTGCCGTGCGGGTGCGGACGGGACCGGACACCCCGCTCGTGGTGCTCTCCGGGGGGATCGACTCCTCCAGTGTCGCGGCGCTGTCCGCCCACCGTTCGGCGGGACGGATCGAGACGGTGTCCATGGGGACGGAGGAAGCCGACGAGTTCCCGCAGGCACGTGTGGTGGCCACCCATCTGGGCTCCGCCCACCGCGAGATCACCGTGTCAATGGCCGATCTGCTGCGCCAGTTGCCGCACGCGGTCTGGGCGGCGGAGTCCCTGGACCCGGACATCGTCGAGTACCTGCTCCCGCTGACGGCCCTGTACCTGCGGCTGGAGGGCAGCGGCCGGCGCATCCTCACCGGGTACGGCGCCGACATACCGCTCGGCGGTATGCACCGCGAGGACCGGCTGCCCCAGCTCGACACGGCCGTCTGCCACGACATGGCGACCTTCGACGGCCTCAACGAGATGACACCGGTCCTCTCCCAGATCAGCGGCCACTGGTCCACCCACCCGTACTGGGACCGTGACGTCCTCGACGTGCTGGTGGCGCTGGAGGCCGGTCTCAAACGGCGCTACGGCCAGGACAAGTGGGTGCTGCGCGCCGCCATGGGTGACCTCCTGCCCCACGAGGTCGTCATCCGTCCCAAGCTCGGCGTCCACGAGGGGTCAGGGGTCACCGCCGCGTTCACCCGGCTGCTGACGGACGCCGGCGTCCCGGACCAACAGGTGCACCGGGCCAAGGAGTTGGTGGTGCAGGAGCTGTTCGACCACGTCGTCGTCGCCGGCCGCCACCCGGACGAGGTGAAGACCGGGGAGGTGGTGGAGCAGGTTGCCGAGCGGCTGGCGTCCGGCGCCACGGCCGCCCTGTGA	MAGSLPAAVGFLAEIRPDGGPPLRPDFASLGGRTELAEDTGGQSLRAVLLHSGAPDGAHARDRGRTVVFAGELYNRDELARLLPAGLSPDSDAALVLALFGSYDVHAFRLLNGRFAALVAAGERVVLATDHAGSVPLYASVAAGRVLAATEAKALRAATGGQPLPARPVRRLTGVHQVPAGTVLDVRVSTAECVAHRTWAPPLARRIVSENEAVETVRQVLDRAVRVRTGPDTPLVVLSGGIDSSSVAALSAHRSAGRIETVSMGTEEADEFPQARVVATHLGSAHREITVSMADLLRQLPHAVWAAESLDPDIVEYLLPLTALYLRLEGSGRRILTGYGADIPLGGMHREDRLPQLDTAVCHDMATFDGLNEMTPVLSQISGHWSTHPYWDRDVLDVLVALEAGLKRRYGQDKWVLRAAMGDLLPHEVVIRPKLGVHEGSGVTAAFTRLLTDAGVPDQQVHRAKELVVQELFDHVVVAGRHPDEVKTGEVVEQVAERLASGATAAL	MQHTIARWVDRLREEYADAVAILLKGSYARGDAATWSDIDFDVLVSTQDVEDYRTWIEPVGDRLVHISAAVEWVTGWERDTVDPSSWSYGLPTQETTRLMWAINDETRRRMDRPYKTHPAAEPEVENTVEALGKIRNAIARGDDLGVYQSAQTVAKLVPTLLIPINPPVTVSHARQAIEAILAFPRVPVGFAADWLTCLGLVEERSARSTAAAAERMVRGVLEMLPTDPDLLGEDIARLMNAGLLEKYVQQ	201.99	gnl|BL_ORD_ID|1252|hsp_num:0	1329		
BGC0001151.1|Clavams_7 # 10117 # 11079 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.700	BGC0001151.1|Clavams_7 	10117	11079	+	Loose	500	26.5646	GOB-11	28.57	3004803	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	GOB beta-lactamase	GTGAACGACCCCGGACAACGGCTCGACATCAACGTCTCTCCTCGTTACGCACAGATCCCCACCTTCATGCGCCTTCCGCACGATCCGTCGCCGCAGGGCAAGGACGTCGTGGTCATCGGCGCCCCGTACGACGGGGGTACCAGCTACCGGCCGGGGGCCCGCTTCGGTCCGCGCGCCGTACGCAACGAATCCGGGCTCATCCACGGCGTCGGCATCGACCGCGGGCCCGGCACCTTCGACCTCATCGACTGCGTGGACGCCGGGGACATCGACCTGACCCCGTTCAACATGCACATCGCGATGGACACGGCGCAGCGGCGCCTGAGCGAACTCCTGGCCGACAACGCCGCCTTCCTGATGATCGGCGGTGACCACTCGCTGACGCTGGCCGCCCTCCGCGCGGTCGCCGCCAAGCACGGTCCGGTGGCCGTCCTGCACCTCGACGCCCACTCGGACACCAACCCCGCCTTCTACGGCGGGGAGTACCACCACGGCACCCCGTTCCGGCACGCCATCGACGAGAAGCTCGTCGACCCGCAGCGCATGCTGCAGATCGGGATCCGGGGCCACAACCCGCAGCCCGACTCACTGGACTACGCCCGTGGACACGGGGTGCGGATCATGACCTCCGACGAGTTCTGCGGCCTCGGTCCCCAGGCCGCCACGGCCCTGGTCCGCGAACACCTCGGCGACGCACCCGTCTACGTGTCGGTGGACGTCGACGTGGTGGATCCGGCGTTCGCCCCGGGCACCGGCACCCCCGCCCCGGGCGGCCCGAGCTCGCGTGAGGTGCTCGCCCTGCTGCGCGGGGTCGGAGACCTGCGCCCGGTGGGCTTCGACGTCATGGAGGTCTCCCCCCTGTACGACCACGGCGGCATCACCTCGGTGCTGGCGACCGAGATAGGGGCCGAACTCCTCTACCAGTACGCACGCTCCACAACCCGAGAAAGGCAGAGCTCGTGA	MNDPGQRLDINVSPRYAQIPTFMRLPHDPSPQGKDVVVIGAPYDGGTSYRPGARFGPRAVRNESGLIHGVGIDRGPGTFDLIDCVDAGDIDLTPFNMHIAMDTAQRRLSELLADNAAFLMIGGDHSLTLAALRAVAAKHGPVAVLHLDAHSDTNPAFYGGEYHHGTPFRHAIDEKLVDPQRMLQIGIRGHNPQPDSLDYARGHGVRIMTSDEFCGLGPQAATALVREHLGDAPVYVSVDVDVVDPAFAPGTGTPAPGGPSSREVLALLRGVGDLRPVGFDVMEVSPLYDHGGITSVLATEIGAELLYQYARSTTRERQSS	MRNFATLFFLSACLSLSLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGTAESLTIIKGNIQKLGFNYKDIKVLLLTQAHYDHTGALEDFKTETGAKFYADKADADVLKTGGKSDYELGKYGVTFKPITPDRTLKDQDKITLGNTTLTLLHHPGHTKGSCSFIFETKDEKRKYRVLIANMPSIIVDKKFSEVAAYPNIQSDYAYTFGAMKKLDFDLWVASHASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLDKIKKDSQDK	109.59	gnl|BL_ORD_ID|2367|hsp_num:0	3597		
BGC0001151.1|Clavams_9 # 12229 # 13374 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.709	BGC0001151.1|Clavams_9 	12229	13374	+	Loose	700	30.0314	vanSA	36.0	3002931	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	GTGCACACGGCACCGGTCGGGCTGGCGGACGACGGGCGCGACGACTTCACCGTCCTGACATCGACCGAACCGGCGGTCGTCAGCGCGGTCTTCACCCGTTCCCTCTTCGCGGGCCCCAGCGTGGTGCTCAGCCGCGCGGCGGTCCGCGACCGCAGCGCCCGGGGCGTCGTCGTCCTGGCCCGCAACGCGAACGTGGCCACCGGCTCGGAGGGCGAACGCAACGCGCGCGAGGTGCGCGACACGGTGGCCCGGGCGGTGGGCGTGGCCGAGGACGAACTCCTCATCGCCTCCACGGGTGTGATCGGCCGTCAGTACCCGATGGAATCCATCCGGGACCACGTCAAGACCCTCACCGCGCCCGAGCCGGGCCATGACGGTTTCCAGCGGGCGGCTCGCGCCATCATGACCACGGACACCCGGCCCAAGGTGGCGCGGGCCCGCGTCGGCGACGCCGTGATCACCGGCATCGCCAAGGGTGTCGGGATGATGGAGCCCGACATGGCCACCCTGCTGACCTTCTTCGCCACCGACGCCCGGCTCGACCCGGAGGAACAGGACCGGATCTTCCGCCGGGTCATGGACCGGACGTTCAACGCGGTCAGCATCGACACGGACACCTCCACCAGCGACACGGCGGCGCTCTTCGCCAACGGACTGGCGGGCGACGTGGACCCCGCGGAGTTCGAGAACGCCCTGTACGAGGTGGCGCTCACCCTGGTCAAGGACATCGCGTCCGACGGAGAGGGCGCGAGCAAGCTGATCGAGGTGCAGGTGAGCGGGGCCCGCGACACCGCGCAGGCCAAACGCGTGGGCAAGGCCGTGGTCAACTCACCCCTGGTGAAGACCGCGGTCCACGGGGGTGACCCGAACTGGGGCCGGGTGGCGATGGCCATCGGCAAGTGCTCCGACGACACGGACATCGACCAGGACAAGGTCGCCATCCGCTTCGGTGAGGTCACGGTCTACCCGCCCGGCCGGCCCGGGGCACAGGACGAGGACGCGGTGCGCGCCGCCGTCGCCGACGAGATGCGCGGCGATCACGTGGTCATCGGCATCGACCTGGCCGTCGCGGACGGCGCCTTCACCGTCTACGGCTGCGATCTGACGGAGGGGTACGTCCGCCTCAACGCCGACTACTCCACCTGA	MHTAPVGLADDGRDDFTVLTSTEPAVVSAVFTRSLFAGPSVVLSRAAVRDRSARGVVVLARNANVATGSEGERNAREVRDTVARAVGVAEDELLIASTGVIGRQYPMESIRDHVKTLTAPEPGHDGFQRAARAIMTTDTRPKVARARVGDAVITGIAKGVGMMEPDMATLLTFFATDARLDPEEQDRIFRRVMDRTFNAVSIDTDTSTSDTAALFANGLAGDVDPAEFENALYEVALTLVKDIASDGEGASKLIEVQVSGARDTAQAKRVGKAVVNSPLVKTAVHGGDPNWGRVAMAIGKCSDDTDIDQDKVAIRFGEVTVYPPGRPGAQDEDAVRAAVADEMRGDHVVIGIDLAVADGAFTVYGCDLTEGYVRLNADYST	MVIKLKNKKNDYSKLERKLYMYIVAIVVVAIVFVLYIRSMIRGKLGDWILSILENKYDLNHLDAMKLYQYSIRNNIDIFIYVAIVISILILCRVMLSKFAKYFDEINTGIDVLIQNEDKQIELSAEMDVMEQKLNTLKRTLEKREQDAKLAEQRKNDVVMYLAHDIKTPLTSIIGYLSLLDEAPDMPVDQKAKYVHITLDKAYRLEQLIDEFFEITRYNLQTITLTKTHIDLYYMLVQMTDEFYPQLSAHGKQAVIHAPEDLTVSGDPDKLARVFNNILKNAAAYSEDNSIIDITAGLSGDVVSIEFKNTGSIPKDKLAAIFEKFYRLDNARSSDTGGAGLGLAIAKEIIVQHGGQIYAESNDNYTTFRVELPAMPDLVDKRRS	99.22	gnl|BL_ORD_ID|1801|hsp_num:0	1907		
BGC0001151.1|Clavams_10 # 13451 # 14095 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.684	BGC0001151.1|Clavams_10 	13451	14095	-	Loose	600	24.2534	Rm3	31.82	3003894	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	Rm3 family beta-lactamase	ATGGCTCTGCTGAACCTGAACCCCGACGAACTGCTCACGACCACCCGATCGGTACGCAAGCGGCTGGACCTGACCCGCCCGGTGCCCCTGGAACTCGTCAAGGAGTGCATCGAGATCGCGCTCCAGGCTCCCACCGGAAGCAACCGCCAGACCTGGCACTGGCTCGTCATCACGGACCCGGACCAGCGTGCCGCGATCGGCGAGTTCTACCGCCGGGCGGTCGACACCTACCTCTCGTCCGAGGGGGCCTGCGGCACGCTCTACCCGGAGGACCCGCAACGCCACGCGGTGCAGAAGCGGGTGGGTGACAGCGTCGCCTACCTGGGGGAGCGGATGAGCGAGGTACCCGTGCTCGTCATCCCCTGCCTGGACGCGAACGAGGCCCCCGAGTACAACGAGGCGGGCATGTGGGGCTCCATCGTCCAGGCCGGGTGGAGTTACATGCTCGCGGCCCGGGCGCGGAGGCTGGGCACCGCCTGGACCACGCTGCACCTGATGTACGAGAAGGAGATCGCCGAGCTGCTGAAGATTCCCGACGGTGTCGTGCAGGCGGCGCTGATTCCGACGGCGTACTCGATCGGCACGGACTTCAAGCCCGCCCGGCGGCAGCCGCTGGACCAGGTCCTCCACCTCGACAGCTGGTGA	MALLNLNPDELLTTTRSVRKRLDLTRPVPLELVKECIEIALQAPTGSNRQTWHWLVITDPDQRAAIGEFYRRAVDTYLSSEGACGTLYPEDPQRHAVQKRVGDSVAYLGERMSEVPVLVIPCLDANEAPEYNEAGMWGSIVQAGWSYMLAARARRLGTAWTTLHLMYEKEIAELLKIPDGVVQAALIPTAYSIGTDFKPARRQPLDQVLHLDSW	MSLTPPRALVLALLLASPGTQAQTPAPATPPTPGCEVCATWNADQAPFRLFGNTYYVGMKGLSSVLVTSPQGHVLIDGGLPESAPKIIANIGALGFRIEDVKLILNSHGHIDHAGGLAELQRRSNALVAASPSAALDLASGEVGPDDPQYHALPKYPPVKDMRLARDGGQFNVGPVYLTAHATPGHTPGGLSWTWQSCDGPRCLNMVYADSINAVSRPGFKFSASSEYPNALADLRHSFETLEKLPCDVLISAHPEASQLWQRLEASATGGSDAFVDPQACRAYVAAARTLLDSRLDQEKQQ	70.86	gnl|BL_ORD_ID|2185|hsp_num:0	2375		
BGC0001151.1|Clavams_11 # 14197 # 15414 # -1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.713	BGC0001151.1|Clavams_11 	14197	15414	-	Loose	800	94.3597	lmrP	25.19	3003969	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGAAACGACGCTCCGCCCAGCAGGGCGGCGGCCTGCCGCGCACCTTCTGGTGGCTGTGGGGTGGAACGCTCATCACGTCCGCGGGCGGGTTCGTCGTGCCGTACCTGGCGATCTACCTGACCAGCGTGCGTGACTACTCGGTGTCCTTCACCGGCCTCGTCATGACGGTGTTCGGCATCGGCAGCGGCCTTGCCGCCTTCGTCGGCGGGATCCTCGCCGACCGCCTGGGGCGTCGGGCGGTGCTGCTGTGGAGCGAGGCGCTGAGTGTCATCGGCATGGCAGGGCTGGGCTTCGCCGACACCAAGGCCCTCGTGGTCGCGGGGACACTGGTCGTGGGGGTCGGGCTCAACGCCACACGGCCGGCTCGCGCCGCGGCCGTCGCCGACCTGGTGAGTGAGGAGGACCGGCCGCGCGCCTACTCGTTGCTGTACTGGGCGACCAACCTGGGATTCTCCGTGGCGGCGGTCAGCGCCGGTGCCGCGGCCGACCAGAGCTTCGCCCTGCTGTTCCTGGTCAACGCGATCGCCAACACGGTCGCGGGCGCCGTCGCCTATCGCTTTGTCCCGGAGACCCGCCCGGAGTCGGCCCGGCCACATCGTGAGCGGGCGGGTGGACGGGGCTCGGCCGTGCTCCGGGACCGGCCGTTCACGGTCCTGCTCGGATCGGTGCTCCTGCTGGGCCTGATGTTCCAGCAGCCGCTGGTGGCCCTGCCCTTGACGATGACGGAGCAAGGGCGTTCACCGGCGGAGTACGGCCTCGTCATGATGGTGAACGGCCTGGTCATCGCGGCGTTCCAGCTGCCGCTGAGCCGGCTGGGCGACCGGTTCCGCCCGGAGCACGCCCTGGCGGTGGCGACCCTGTTCTCCGGCATCGGCTTCGGCCTCACCGGAGTGGTCCAGAGCCTTCCGGGATACGCGGCGACCGTGGTGCTGTGGAGCCTGGGAGAGATCGTCGTCCTGCCGCGGTGCATGACACTCGTCGCCCTCCTGGCCCCGGCGCACGCCCAAGGCAGTTACCAGGGACGCCTGTTGCTGGTGTGGAGCTCCGCCGTGGCCCTGGCCCCGCTCCTGAGCAGCCAGCTGATCGAGGCGTCCGGCACCACCGCGGTCTGGGTCGCCTGTACGGCGCTGGGCCTGCTGGCCGCCGCCCTCCACCTCGTCCTGGGCCGGCTGCGCCGCAAGCCGGTGCACGAGGAAGCCGAACCCCTGCCTTCCTGA	MKRRSAQQGGGLPRTFWWLWGGTLITSAGGFVVPYLAIYLTSVRDYSVSFTGLVMTVFGIGSGLAAFVGGILADRLGRRAVLLWSEALSVIGMAGLGFADTKALVVAGTLVVGVGLNATRPARAAAVADLVSEEDRPRAYSLLYWATNLGFSVAAVSAGAAADQSFALLFLVNAIANTVAGAVAYRFVPETRPESARPHRERAGGRGSAVLRDRPFTVLLGSVLLLGLMFQQPLVALPLTMTEQGRSPAEYGLVMMVNGLVIAAFQLPLSRLGDRFRPEHALAVATLFSGIGFGLTGVVQSLPGYAATVVLWSLGEIVVLPRCMTLVALLAPAHAQGSYQGRLLLVWSSAVALAPLLSSQLIEASGTTAVWVACTALGLLAAALHLVLGRLRRKPVHEEAEPLPS	MQEFLNLPKQIQLRQLVRFVTITLGSSIFPFMAMYYTTYFGTFWTGLLMMITSLMGFVGTLYGGHLSDALGRKKVIMIGSVGTTLGWFLTILANLPNAAIPWLTFAGILLVEIASSFYGPAYEAMLIDLTDESNRRFVYTINYWFINIAVMFGAGLSGLFYDHHFLALLVALLLVNVLCFGVAYYYFDETRPETHAFDHGKGLLASFQNYRQVFQDRAFVLFTLGAIFSGSIWMQMDNYVPVHLKLYFQPTAVLGFQVTSSKMLSLMVLTNTLLIVLFMTVVNKLTEKWKLLPQLVVGSLLFTLGMLLAFTFTQFYAIWLSVVLLTFGEMINVPASQVLRADMMDHSQIGSYTGFVSMAQPLGAILASLLVSVSHFTGPLGVQCLFVVIALLGIYFTVVSAKMKKV	99.75	gnl|BL_ORD_ID|2250|hsp_num:0	2435		
BGC0001151.1|Clavams_12 # 15452 # 16720 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.723	BGC0001151.1|Clavams_12 	15452	16720	-	Loose	650	60.077	vanD	29.19	3000005	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	ATGCCGCAACGCCCGAAGATTGTTCTCGTCGGCCAACTCGTCACCGCCCCCTGGGTGTTCGAGGCCGCCCAGCGTGTGGGCGTCGACGTGGTGCTCATCCCCTGGACGGGCACCGACCTGGACGTGGCACGGCGGGCCGCCGCGGTGACGGAGGTCCTGCCCCTGGACGTGGAGACGGATCCGGACGGGGCGCTGGCGGCTCTGGTCGAGCGCTTTCGGTCGGACCCCTTCGACGGGATCATGGCGGGCAACGAACTGGTCGTCCCCTTCACCGCGCGTGCCGCACGCACCCTCGGTCTCCCCGGTCTGTCCGAACAGGGCGCGGCGGTGGTGCGCGACAAGCGCAGCATGCGGCAGCGCCTGGCGGAGGCGGGCCTGGCGGTCCCCGGTCTTGCCGCCCTGGAGCGCAAGGAGGACTGGGCCGACGCACTGACACTGCGGTTCCCGGTCGTGGTGAAGCCGGCGCGCGGCTTCTCCAGCCTCGGCGTCATCCGGGTCGACGACAAGGAGCAGCTCGAACAGGCCGTCAGCAGTACCTGGGAGCTCGTGGAGGCCCGTTCGCACAAGCCCGCCGAAACGGGTGGCGGCAGCGGAGTGCTGGTCGAGGAGTACCTGGACGGACCGGAGATCTCAGCCGAGTCCCTGGTCCACCGGGGCCGGGTGCGGGTGTGCGCGGTCTCCTGGAAGGGGGAACTCACCGGCCCCTACTTCGAGGAGACCACGCTGCGCGCACCGGCCCGGCTGCCGGCCGAGATCCTGGCCGCCGTCGAAGCGGAAGTGGTCGCCGCCCACCACGCCTTCGGCGTCGACGAGGGTGCCACCCACACCGAGCTGCGCCTGGTCGGCGGGGTGCGTCCGGTGCTGCTGGAGATGGGCGCGCGCATCGGAGGCGGCGGGTTCATGCACCACCTCGTCCGGGGGAGCAGCGGCATCGACTTCGCGGCCGAGACCGTACGCATCCATCTGGGGCAGGAGCCCCGGTGCTGGTCGCAGGAGCCGGTGGCGGCCGGACACGCGGCCGCCTACCTGGTCCCGGTCGGCACCGGCGGCACCTTCCGGCGCATCCGGGGCCTGGACGAGGTCCGTGCCGACCCCCGGGTCGACCACGTGGCACAGGCCGTCGCCCCCGGAGCGGTGCTGCGCCCGTACCCGGCGTGGACCGCGTATCCGGCGATCGTGCTGTCCCACCACGCGTCGGACGAGGAGGCCGTGCAGTTCCGCGAGCACCTCGAAAGGACCCTGCACATCGAGTACGAGGAGCAGGGGTGA	MPQRPKIVLVGQLVTAPWVFEAAQRVGVDVVLIPWTGTDLDVARRAAAVTEVLPLDVETDPDGALAALVERFRSDPFDGIMAGNELVVPFTARAARTLGLPGLSEQGAAVVRDKRSMRQRLAEAGLAVPGLAALERKEDWADALTLRFPVVVKPARGFSSLGVIRVDDKEQLEQAVSSTWELVEARSHKPAETGGGSGVLVEEYLDGPEISAESLVHRGRVRVCAVSWKGELTGPYFEETTLRAPARLPAEILAAVEAEVVAAHHAFGVDEGATHTELRLVGGVRPVLLEMGARIGGGGFMHHLVRGSSGIDFAAETVRIHLGQEPRCWSQEPVAAGHAAAYLVPVGTGGTFRRIRGLDEVRADPRVDHVAQAVAPGAVLRPYPAWTAYPAIVLSHHASDEEAVQFREHLERTLHIEYEEQG	MYKLKIAVLFGGCSEEHDVSVKSAMEVAANINKEKYQPFYIGITKSGAWKLCDKPCRDWENYAGYPAVISPDRRIHGLLIQKDGGYESQPVDVVLPMIHGKFGEDGTIQGLLELSGIPYVGCDIQSSVICMDKSLAYMVVKNAGIEVPGFRVLQKGDSLEAETLSYPVFVKPARSGSSFGVNKVCRAEELQAAVTEAGKYDSKILVEEAVSGSEVGCAILGNGNDLITGEVDQIELKHGFFKIHQEAQPEKGSENAVIRVPAALPDEVREQIQETAKKIYRVLGCRGLARIDLFLREDGSIVLNEVNTMPGFTSYSRYPRMMTAAGFTLSEILDRLIGLSLRR	123.03	gnl|BL_ORD_ID|778|hsp_num:0	824		
BGC0001151.1|Clavams_13 # 16885 # 17814 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.701	BGC0001151.1|Clavams_13 	16885	17814	-	Loose	700	28.8758	ACT-22	25.0	3001843	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	ATGAGCAGTGGAGCAGTGGAACAGAACTACGCGCAGAATCTGACCTTCATGGGAATCCCTCGCCATGCTTCTCCGCGCGGCCGGGACCTGGTGGTGATCGGCGCCCCGTACGATGCCGGCACCAGTCATCGGCCCGGGACCCAGCTGGGCCCGCGGGCCATTCGGCAGGGCTCGGACCTCCTTCTCGGCACAGGTTTCGGCCGGGGGCCCGCGGCCTCCGACATCATCGACTGCGCGGACGCCGGGGACATCGACCTGGGCCCGTGCGACGCGCGCACGGTCTTGGAGGTTGCGCAGCGGAGCCTGCAGTCCCTGCTGGAGCACAACGACGCGTTCCTGATGCTGGGGGGCGACCACGCGCTCACGCTTGCGGCGCTGCGGGCAGTCGTCCGCAGGCACGGGATGGTCGCCGCGGTGCATCTCGACGCGCACTGCGACACCCAACCGGACGTCTACGGCACCGAATACCACCACGGCACGACGTTCCGTCAGGCCATCGAGGAGAGGCTGATCGACCCTCGGCGACTCGTGCAGATCGGGGTCCGCGGCCCTCGGGTCGAACCCGACCCGCAGGACGGCGCCCGAAGACACGGCACACGGGTCATCACCGCCGCCGACATGGTCGCCGTGGGCCCCTCCGCCACCGCTCGCCTGATCCGCGAGATCATCGGAGACGTACCGGTCTACGTGTCGGTCGGCATGGACGTCGTGGATCCGAGGTTCGCGCCCGGCACCGCGGCGCCGGCACCGGACGGGCCCTCCTCGCTCGACGTCCTCGAAGTGCTGCGCTGTGTCGGTGATCTGGAGCCCGTCGGCTTCGACGTGATGGGCGTCTGCCCGCCCTACGACCACGGCGGTGTCACGTCCCTCCTGGCCACCGAGGTGGGCGCGGAGCTGCTCTACCAGTTCGCACGGTCCCGTTGCCGGTGA	MSSGAVEQNYAQNLTFMGIPRHASPRGRDLVVIGAPYDAGTSHRPGTQLGPRAIRQGSDLLLGTGFGRGPAASDIIDCADAGDIDLGPCDARTVLEVAQRSLQSLLEHNDAFLMLGGDHALTLAALRAVVRRHGMVAAVHLDAHCDTQPDVYGTEYHHGTTFRQAIEERLIDPRRLVQIGVRGPRVEPDPQDGARRHGTRVITAADMVAVGPSATARLIREIIGDVPVYVSVGMDVVDPRFAPGTAAPAPDGPSSLDVLEVLRCVGDLEPVGFDVMGVCPPYDHGGVTSLLATEVGAELLYQFARSRCR	MMKKSLCCALLLSTSCAALAAPMSETQLAKVVARTVTPLMKAQSIPGMAVAVIYQGQPHYFTFGKADVAANTPVTAQTLFELGSISKTFTGVLGGDAIARGEISLSDPVTKYWPELTGKQWQGVRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQSWQPQWAPGTTRLYANASIGLFGALAVKPSGMRFEQAMTERVLKPLNLNHTWINVPKAEEQHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVKDMASWVVANMAPDGVQDASLKQGMALAQSRYWRTGSMYQGLGWEMLNWPVEAKTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKKLGIVMLANKSYPNPARVEAAYRILSALQ	81.10	gnl|BL_ORD_ID|373|hsp_num:0	401		
BGC0001151.1|Clavams_14 # 18277 # 18474 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.652	BGC0001151.1|Clavams_14 	18277	18474	+	Loose	650	23.0978	TriA	37.5	3003679	protein homolog model	n/a	n/a	triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGAACAGGATCACATACGCAGCCTCTCGCGTGCCGTCGCGTTGGCCTTGGCCGCCACCGCCCTGGCAGTGACAGGGATCTACGCCCCACTGGCACAGGCATCGATGGTCAGCACCGCAGGCCAGACACTCACGTCCCCGACCGGGGCCGAGGGGATGCTCACTGAGGAGGACAACGACATTCCCGTCTGCTGCTAG	MEQDHIRSLSRAVALALAATALAVTGIYAPLAQASMVSTAGQTLTSPTGAEGMLTEEDNDIPVCC	MSDARGAFHSKGRWSRMALPAILCAGLLVGCGAEPPAEEHVRVLAQTVKMAEFASATSITGDIQARVQADQSFRVGGKIVERLVDVGDHVAAGQVLARLDPQDQRSNVENAQAAVAAQQAQSKLADLNYQRQKALLPKGYTSQSEYDQALASVRSAQSSLKAAQAQLANARDLLSYTELRASDAGVITARQAEVGQVVQATVPIFTLARDGERDAVFNVYESLFSHDVDGQRITVSLLGKPEVTASGKVREITPTVDERSGTLKVKVGLDSVPAEMSLGSVVNASVAAPAEHSVVLPWSALSKVGEQPAVWLLDQQGKARLQPVRVARYASEKVVIDGGLEAGQTVVTVGGQLLHPGQVVEVAQPPQPTQSTASRDAVGGGQP	16.97	gnl|BL_ORD_ID|2047|hsp_num:0	2192		
BGC0001151.1|Clavams_15 # 18566 # 19852 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.702	BGC0001151.1|Clavams_15 	18566	19852	-	Loose	700	25.0238	CMY-101	30.77	3002113	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGTCCCAGGCGGATCTGGCAGGTGACGGACTGTCACCCAGCTACATCTCCCTCGTCGAGGCGGGCAAGCGGTCGCCGTCGCCCGAGGTGCTCGCGCAGCTGGCCGCGCGACTTCACTGTGACGTGGCGGAGCTGGGGGGTGAGCCCGCGGTGTCCGTCACCGGGCTCGCGGTGGAACTGAGCTTCGCGGAGACGGCGTTGAACGCCGGCGATGCCCAGGCGGCGCGTGAGGCGTACCTGGCCGTGCGCGCCAAAGTGGGCAAGTCCTCGCAGCCCGAGTCCTGGTACAAGGCGACCTACGGTCTGGCCCGTGCCCTGGAGAACCTCGGCGAGCTGGAGGAGGCGGTCGTGCACCTGGAGGAGCTCCACGCCACCGCGGTGGCCCAGCCCGACTCGGTGCCCCGTCTGACCACGGTGATCGCGCTGTGCCGCTGCTACCGGGAACTCGGCGATCTCTCCCACGCCATCGAGGTGGCCGAGGACACGCTCGCCGAACTGGACGAGCTCGGCCTGGCGCCCACGGTCGTAGGCGTCGAACTGCTGTCGACGCTCGTCGGCGTCCACATGGAGCGCGGAGACCTGCACCGTGCCTCGTACCTGGCCGGAAAGGCCATCGAGCAGGCCGACTCGGTCACCGACGCCCGCGCCCGGGGCGCGGCGTACTGGAACGCCAGTGTCGTCCTGCACCGCAACGGCAAGACGGCCGACGCCCTGGTGCTGATCGAGAAGGCGCTGGCGTGTTACGCCGAAGGAGAGGACACGCGTGCGCTCGCGCGGCTGCGCAACGCCTACGCCATGCTGCTGCTGGAGTCCGGGAGCACGGAGCCGGAGCCGGTGCGCGAGATGCTCCAGCAGAGCTACGCGTCCTTGCGCGAGGTGGGCAGCAGCGTGGACGTCGCCTACTGCCTGTCGGCCCTGGCCCGGATGGAGTTGCGGCTGGGCGATCCCCTGTCGGCCGTCCGCAACGCGGAGGAGGCGCTGGAGCTCCTCGGCACGCAGCACCGTCTGCAAAGCGCGCGGAACTACCTGGTGCTCGCCGCCGCTCACCTCGCGATGGGGCGGACCGAAGCCTGTCAGGAGGCCTATGAGCGGGGCGCTTTGATGCTGGAGGCTTCCGAGGCCAACCGTCAGGCAGGTTTCGCCTGGGCCGAGTTGGCGGAGATCTTCCGGTTGTGCGGGGAGGAGGCGCGTGCGGTGTGGGCGTACCGGCAGAGCGTGCGCTGCCTGGGACACCGGGAGGCATTTTCCGAGGATGCGCTTGAGCAGTCACCGACGACGGGGGGCTGA	MSQADLAGDGLSPSYISLVEAGKRSPSPEVLAQLAARLHCDVAELGGEPAVSVTGLAVELSFAETALNAGDAQAAREAYLAVRAKVGKSSQPESWYKATYGLARALENLGELEEAVVHLEELHATAVAQPDSVPRLTTVIALCRCYRELGDLSHAIEVAEDTLAELDELGLAPTVVGVELLSTLVGVHMERGDLHRASYLAGKAIEQADSVTDARARGAAYWNASVVLHRNGKTADALVLIEKALACYAEGEDTRALARLRNAYAMLLLESGSTEPEPVREMLQQSYASLREVGSSVDVAYCLSALARMELRLGDPLSAVRNAEEALELLGTQHRLQSARNYLVLAAAHLAMGRTEACQEAYERGALMLEASEANRQAGFAWAELAEIFRLCGEEARAVWAYRQSVRCLGHREAFSEDALEQSPTTGG	MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYYFTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTHYWPELTGKQWQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTKRVLHPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMTRWVQANMDASQVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPVKADSIISGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ	112.34	gnl|BL_ORD_ID|1281|hsp_num:0	1364		
